(Q34627959)

3 August 2017

title

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

P Österlund

1

1 reference

3 August 2017

L-M Soveri

2

1 reference

3 August 2017

H Isoniemi

3

1 reference

3 August 2017

T Poussa

4

1 reference

3 August 2017

T Alanko

5

1 reference

3 August 2017

P Bono

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

8 February 2011

1 reference

British Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

104

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

599-604

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.2

3 August 2017

exact match

0 references

cites work

Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Predicting benefit from anti-angiogenic agents in malignancy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049598

Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.2

Toxicity of sunitinib plus bevacizumab in renal cell carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.2

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2011.2

21 January 2018

Identifiers

DOI

10.1038/BJC.2011.2

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference